Cafepharma Today

June 20 2025 - Gene therapy faces fresh uncertainty as two more top FDA officials depart
Gene therapy faces fresh uncertainty as two more top FDA officials depart
Eli Lilly (LLY) sees strong demand for Mounjaro in India
A longer ‘winter’: Public funding slowdown heightens pressure on biotech startups
Is DTC pharma advertising coming to an end?
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Some pharmaceutical mergers lower drug prices: Study
Beckers Hospital Review
Thursday, January 9, 2025 - 9:15pm
tags:
M&A, drug pricing
Sanofi scores with its subcutaneous version of Sarclisa as it tries to play catch up with J&J's Darzalex
Fierce Pharma
Thursday, January 9, 2025 - 11:55am
tags:
JNJ, Darzalex, Sanofi, Sarclisa, Multiple Myeloma
Boston Scientific to buy remaining Bolt Medical stake for up to $664M
Medtech Dive
Thursday, January 9, 2025 - 11:28am
tags:
Boston Scientific, M&A, Medtech, Bolt Medical
Catalyst settles with Teva, staving off Firdapse generic until 2035
Fierce Pharma
Thursday, January 9, 2025 - 11:25am
tags:
Teva Pharmaceutical, Firdapse, Catalyst Pharmaceuticals, generics
Lilly crafts deal for up to 5 new ALS antibodies with UK biotech Alchemab
Fierce Biotech
Thursday, January 9, 2025 - 11:18am
tags:
Eli Lilly, ALS, Alchemab Therapeutics
After Drug Rejection, Vanda Blasts ‘Unacceptable’ FDA Conduct in Letter to Commissioner
BioSpace
Thursday, January 9, 2025 - 11:15am
tags:
Vanda Pharmaceuticals, Robert Califf, regulatory
Cristcot‘s Phase III ulcerative colitis suppository trial meets endpoints
Clinical Trials Arena
Thursday, January 9, 2025 - 11:13am
tags:
Cristcot, clinical trials, ulcerative colitis
Bayer makes hot flash splash, hitting phase 3 breast cancer goal to steal march on Astellas
Fierce Biotech
Thursday, January 9, 2025 - 11:11am
tags:
Bayer, hot flashes, clinical trials, breast cancer, elinzanetant
After layoffs, a viral immunotherapy biotech bounced back with a late-stage prostate cancer win
Pharma Voice
Thursday, January 9, 2025 - 11:09am
tags:
Candel Therapeutics, cancer immunotherapy, prostate cancer
Drug price talks provide an early test for Trump
Axios
Thursday, January 9, 2025 - 11:07am
tags:
drug pricing, Donald Trump, Medicare
Verdiva Bio raises $411m for obesity pipeline
Pharmaphorum
Thursday, January 9, 2025 - 11:06am
tags:
Verdiva Bio, obesity, funding
MaaT Pharma Phase III microbiome trial hits endpoints as stock soar
Clinical Trials Arena
Thursday, January 9, 2025 - 11:05am
tags:
MaaT Pharma, microbiome, clinical trials, MaaT013
Launches from Novo, Lilly top Clarivate's annual 'Drugs to Watch' list
Fierce Pharma
Wednesday, January 8, 2025 - 11:20pm
tags:
Novo Nordisk, Awiqli, insulin, CagriSema, Eli Lilly, Ebglyss
J&J Halts PFA Cases Amid Stroke Reports
Medical Devices and Diagnostics Industry
Wednesday, January 8, 2025 - 11:18pm
tags:
Medtech, JNJ, Varipulse, stroke, pulse field ablation
Scribe slims down workforce as it readies cardiometabolic genetic meds for clinic
Fierce Biotech
Wednesday, January 8, 2025 - 11:14pm
tags:
Scribe Therapeutics, cardiometabolic diseases, CRISPR
Phillips Medisize Boosts Medical Inhaler Portfolio With Vectura Acquisition
Medical Devices and Diagnostics Industry
Wednesday, January 8, 2025 - 11:11pm
tags:
Medtech, Phillips Medisize, M&A, Vectura Group
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, Health Department agency says
CNBC
Wednesday, January 8, 2025 - 11:07pm
tags:
Eli Lilly, Zepbound, Medicare, sleep apnea
Clinical trial trends in 2025: Investment headwinds, wearables, and targeted AI uses
Clinical Trials Arena
Wednesday, January 8, 2025 - 11:05pm
tags:
clinical trials, CROs, wearables, artificial intelligence
Tenvie unveils with $200M and a neuro pipeline with assets from Denali
Fierce Biotech
Wednesday, January 8, 2025 - 11:36am
tags:
Tenvie Therapeutics, Denali Therapeutics, neurological disorders
Alesta Therapeutics Raises €65 Million Series A Financing to Advance Oral Small Molecules for Rare Diseases
PR Newswire
Wednesday, January 8, 2025 - 11:33am
tags:
Alesta Therapeutics, funding, rare disease, small molecule drugs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Stir Bars Can't Be Ignored
In the Pipeline
AI Effects on Drug Patents
In the Pipeline
Mirror Morphine
In the Pipeline
Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.